156 related articles for article (PubMed ID: 21145096)
1. Analysis of postoperative complications associated with the use of anti-adhesion sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier after cytoreductive surgery for ovarian, fallopian tube and peritoneal cancers.
Krill LS; Ueda SM; Gerardi M; Bristow RE
Gynecol Oncol; 2011 Feb; 120(2):220-3. PubMed ID: 21145096
[TBL] [Abstract][Full Text] [Related]
2. Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for ovarian, fallopian tube, or primary peritoneal cancers.
Leitao MM; Natenzon A; Abu-Rustum NR; Chi DS; Sonoda Y; Levine DA; Gardner GJ; Barakat RR
Gynecol Oncol; 2009 Nov; 115(2):204-8. PubMed ID: 19740532
[TBL] [Abstract][Full Text] [Related]
3. Prevention of adhesion formation after radical oophorectomy using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier.
Bristow RE; Montz FJ
Gynecol Oncol; 2005 Nov; 99(2):301-8. PubMed ID: 16085295
[TBL] [Abstract][Full Text] [Related]
4. Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Shih KK; Chi DS; Barakat RR; Leitao MM
Gynecol Oncol; 2010 Mar; 116(3):364-9. PubMed ID: 19897231
[TBL] [Abstract][Full Text] [Related]
5. Recurrence patterns of advanced ovarian, fallopian tube, and peritoneal cancers after complete cytoreduction during interval debulking surgery.
Usami T; Kato K; Taniguchi T; Abe A; Nomura H; Yamamoto A; Matoda M; Okamoto S; Kondo E; Omatsu K; Kawamata Y; Takeshima N
Int J Gynecol Cancer; 2014 Jul; 24(6):991-6. PubMed ID: 24905612
[TBL] [Abstract][Full Text] [Related]
6. Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers.
Long KC; Levinson KL; Diaz JP; Gardner GJ; Chi DS; Barakat RR; Leitao MM
Gynecol Oncol; 2011 Jan; 120(1):33-7. PubMed ID: 20947151
[TBL] [Abstract][Full Text] [Related]
7. The use of sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier in gynecologic malignancies: a retrospective review of outcomes.
Tan A; Argenta P; Ramirez R; Bliss R; Geller M
Ann Surg Oncol; 2009 Feb; 16(2):499-505. PubMed ID: 19018596
[TBL] [Abstract][Full Text] [Related]
8. Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer.
Bashir S; Gerardi MA; Giuntoli RL; Montes TP; Bristow RE
Gynecol Oncol; 2010 Nov; 119(2):255-8. PubMed ID: 20739051
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of video laparoscopic surgical debulking of recurrent ovarian, fallopian tube, and primary peritoneal cancers.
Nezhat FR; Denoble SM; Cho JE; Brown DN; Soto E; Chuang L; Gretz H; Saharia P
JSLS; 2012; 16(4):511-8. PubMed ID: 23484556
[TBL] [Abstract][Full Text] [Related]
10. Use of ablation and ultrasonic aspiration at primary debulking surgery in advanced stage ovarian, fallopian tube, and primary peritoneal cancer.
Li S; Manning-Geist B; Gockley A; Ramos A; Sisodia RC; Del Carmen M; Growdon WB; Horowitz N; Berkowitz R; Worley M
Int J Gynecol Cancer; 2020 Jul; 30(7):1052-1057. PubMed ID: 32487686
[TBL] [Abstract][Full Text] [Related]
11. The incidence of major complications after the performance of extensive upper abdominal surgical procedures during primary cytoreduction of advanced ovarian, tubal, and peritoneal carcinomas.
Chi DS; Zivanovic O; Levinson KL; Kolev V; Huh J; Dottino J; Gardner GJ; Leitao MM; Levine DA; Sonoda Y; Abu-Rustum NR; Brown CL; Barakat RR
Gynecol Oncol; 2010 Oct; 119(1):38-42. PubMed ID: 20609464
[TBL] [Abstract][Full Text] [Related]
12. Postoperative intra-abdominal collections using a sodium hyaluronate-carboxymethylcellulose (HA-CMC) barrier at the time of laparotomy for uterine or cervical cancers.
Leitao MM; Byrum GV; Abu-Rustum NR; Brown CL; Chi DS; Sonoda Y; Levine DA; Gardner GJ; Barakat RR
Gynecol Oncol; 2010 Nov; 119(2):208-11. PubMed ID: 20708225
[TBL] [Abstract][Full Text] [Related]
13. The impact of ultra-radical surgery in the management of patients with stage IIIC and IV epithelial ovarian, fallopian tube, and peritoneal cancer.
Turnbull HL; Akrivos N; Wemyss-Holden S; Maiya B; Duncan TJ; Nieto JJ; Burbos N
Arch Gynecol Obstet; 2017 Mar; 295(3):681-687. PubMed ID: 27995370
[TBL] [Abstract][Full Text] [Related]
14. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
[TBL] [Abstract][Full Text] [Related]
15. Cytoreductive surgery for advanced ovarian cancer.
Pölcher M; Zivanovic O; Chi DS
Womens Health (Lond); 2014 Mar; 10(2):179-90. PubMed ID: 24601809
[TBL] [Abstract][Full Text] [Related]
16. Laparoscopic intraperitoneal port placement for optimally cytoreduced advanced ovarian cancer.
Janco JM; Hacker MR; Konstantinopoulos PA; Cannistra SA; Awtrey CS
J Minim Invasive Gynecol; 2011; 18(5):629-33. PubMed ID: 21803662
[TBL] [Abstract][Full Text] [Related]
17. A multicentre, randomised, controlled trial to assess the safety, ease of use, and reliability of hyaluronic acid/carboxymethylcellulose powder adhesion barrier versus no barrier in colorectal laparoscopic surgery.
Berdah SV; Mariette C; Denet C; Panis Y; Laurent C; Cotte E; Huten N; Le Peillet Feuillet E; Duron JJ
Trials; 2014 Oct; 15():413. PubMed ID: 25348087
[TBL] [Abstract][Full Text] [Related]
18. A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.
Chi DS; Zivanovic O; Palayekar MJ; Eisenhauer EL; Abu-Rustum NR; Sonoda Y; Levine DA; Leitao MM; Brown CL; Barakat RR
Gynecol Oncol; 2009 Jan; 112(1):6-10. PubMed ID: 19100916
[TBL] [Abstract][Full Text] [Related]
19. Patterns of recurrence in advanced epithelial ovarian, fallopian tube and peritoneal cancers treated with intraperitoneal chemotherapy.
Esselen KM; Rodriguez N; Growdon W; Krasner C; Horowitz NS; Campos S
Gynecol Oncol; 2012 Oct; 127(1):51-4. PubMed ID: 22659193
[TBL] [Abstract][Full Text] [Related]
20. Role of maximal primary cytoreductive surgery in patients with advanced epithelial ovarian and tubal cancer: Surgical and oncological outcomes. Single institution experience.
Peiretti M; Zanagnolo V; Aletti GD; Bocciolone L; Colombo N; Landoni F; Minig L; Biffi R; Radice D; Maggioni A
Gynecol Oncol; 2010 Nov; 119(2):259-64. PubMed ID: 20800269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
